Wockhardt Ltd. is a global pharmaceutical and biotechnology organisation, providing affordable, high-quality medicines for a healthier world. It is India’s leading research-based global healthcare enterprise with relevance in the fields of Pharmaceuticals, Biotechnology and a chain of advanced Super Speciality Hospitals. It is a true Indian Multi-National Company with a multi-ethnic workforce of many Wockhardt Associates from many different nationalities globally. It has many research centres and several manufacturing plants, with businesses ranging from the manufacture and marketing of Pharmaceutical and Bio-pharmaceutical formulations, Active Pharmaceutical Ingredients (APIs) and Vaccines. It is a business in transition. New and innovative business models are in motion to make the most of emerging opportunities. A new drive for growth today permeates every mind-set, process and techno-innovation within Wockhardt.

Business area of the company

The company is a pharmaceutical and biotechnology company. The Company's businesses include manufacture and marketing of pharmaceutical and bio-pharmaceutical formulations, active pharmaceutical ingredients (APIs) and vaccines.

Wockhardt Ltd.

Indoco Remedies Ltd.

AMI Organics Ltd.

Advanced Enzyme Technologies Ltd.

Unichem Laboratories Ltd.

Strides Pharma Science Ltd.

Hikal Ltd.

Aarti Drugs Ltd.

Shilpa Medicare Ltd.

Sequent Scientific Ltd.

Marksans Pharma Ltd.

Neuland Laboratories Ltd.

FDC Ltd.

Amrutanjan Health Care Ltd.

Gufic Biosciences Ltd.

HDFC Bank Ltd.

ICICI Bank Ltd.

ITC Ltd.

Reliance Industries Ltd.

Tata Motors Ltd.

Market Cap	3,392 Cr		EPS	-9.7		High	239.65
Stock P/E	0.0		Net Profit Margin	-30.5		Low	236.5

Open Price	238.45	Volume	461
Prev. Close	238.45

WOCKPHARMA